Microneedling at home: a careful no

Verdict № 01

Tier D

0.5 mm at-home dermarollers

Skip

Two new dermaroller brands sent us samples. The 0.5 mm needle length crosses into wound territory: real bleeding, real disruption of the stratum corneum, real infection risk in non-clinical hands. The cosmetic-grade rollers tested showed measurable burr defects under microscopy after one use, which compounds the trauma rather than the benefit. The procedure-grade alternative (clinic SkinPen, Dermapen) operates at controlled depth, with sterile single-use cartridges, and produces the published outcomes. Roller use at home produces injuries; clinic use produces results.

Bottom line

Send the rollers back. Book a clinic session if you want the endpoint.

Verdict № 02

Tier B

0.25 mm dermastamps

Partly True

Below 0.3 mm needle length, the procedure shifts from wounding to topical-penetration enhancement, and the safety profile narrows substantially. The literature on 0.2–0.25 mm dermastamps as adjuncts for topical actives is small but generally positive — particularly for vitamin C, peptide, and growth-factor delivery. Sterile single-use stamps, clean skin, and a sensible product to deliver afterwards. Not a replacement for clinical microneedling; a defensible at-home enhancer when used with discipline.

Bottom line

Defensible at 0.2–0.25 mm. Above that, see a clinic.

0.5 mm at-home dermarollers

0.25 mm dermastamps

Once a fortnight. Never a sell.